Clin Infect Dis

1. 
   Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
   Clin Infect Dis. 2026 Jan 9:ciaf711. doi: 10.1093.
   

   >> Share

   
   

   
   Emerg Infect Dis

2. KURBATOVA EV, Whitworth WC, Bryant KE, Dixon MG, et al
   Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.
   Emerg Infect Dis. 2025;31:2233-2242.
   

   >> Share

   
   

   
   J Infect Dis

3. YATES TA, Barr DA
   Re: Estimating the Early Transmission Inhibition of New Treatment Regimens for Drug-Resistant Tuberculosis.
   J Infect Dis. 2026 Jan 9:jiaf655. doi: 10.1093.
   

   >> Share

   
   

   
   PLoS One

4. DA SILVA JMN, Diaz-Quijano FA, Maia LTS, Sanchez MN, et al
   Space-time clustering and temporal trend analysis of pulmonary tuberculosis in Brazil, 2010-2023.
   PLoS One. 2026;21:e0339784.
   

   >> Share

   
   
5. KAVE S, Sikweyiya Y, Khuzwayo N
   Gender-transformative health promotion interventions for linking and retaining tuberculosis-diagnosed adult men in care in sub-Saharan Africa: A scoping review protocol.
   PLoS One. 2026;21:e0339666.
   

   >> Share

   
   
6. LYNESS G, Verlander NQ, Beck CR
   Exposures associated with tuberculosis presentation and healthcare delays in South West England, 2015-2020.
   PLoS One. 2026;21:e0340187.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share